Dr. Jones Discusses Clinical Research in Middle Georgia on 41NBC

Wednesday, January 4th, 2012

Cheryl Jones, MDDr. Cheryl Jones recently appeared on 41NBC to talk about Georgia Cancer Specialists’ role in advancing cancer treatment through participation in clinical trials. Watch the video clip here.

The GCS-Macon office completed two trials on breast cancer prevention, one of which led to the FDA approval of the drug Raloxifene, which is used to decrease the risk of developing invasive breast cancer in women at high risk.

“If more patients are willing to participate in clinical trials, more people are likely to live cancer free,” said. Dr. Jones, the site principal investigator at the GCS-Macon office. 

Christine Dwight first saw Dr. Jones in 2004 after undergoing a year of chemotherapy to treat her breast cancer. She was enrolled in a clinical trial for Herceptin, a drug that has since been approved to treat HER2+ breast cancer.

Dwight is now in remission and spreads her positive attitude to those who are currently undergoing cancer treatment by volunteering at the GCS-Macon office once a week.

“When you do research, you’re helping someone else to get better, to do well, and if you don’t try it, you’ll never know,” Dwight said. “Through that journey, I lived to help somebody else.”

The GCS research department participates in the latest and most advanced clinical trials and is the only private cancer practice in Georgia to offer Phase I trials.

“[Patients] don’t need to travel out of the state or elsewhere to be on the cutting edge,” Dr. Jones said.

Georgia Cancer Specialists is a Top 10 private cancer practice in the U.S. and a leader in advanced cancer treatment and research. The practice supports more than 200,000 patient visits each year. GCS offers community-based medical oncology and hematology services and is the first private oncology practice to also provide a full range of support services for patients in Georgia, including wellness counseling and home health coordination. The GCS research department, whose focus is bringing targeted cancer therapy to communities, is the first in Georgia to offer Phase I clinical trials, the most novel cancer therapies available. GCS has 27 offices, 44 physicians, and more than 500 support staff members located in Metro Atlanta, and North and Central Georgia. Georgia Cancer Specialists can be found on the web at www.gacancer.com GCS is The Cancer Answer.

© 2024, GEORGIA CANCER SPECIALISTS Administrative Annex . All Rights Reserved.